Not only is it violating our patents, which we take very seriously, but it's really a direct challenge to the entire drug approval framework in the United States." Hims & Hers officials declined an interview request but said in a statement that treating obesity requires "precision and personalization." The company still sells injectable GLP-1 medications
Luciferase substrate coelenterazine (5 M, Thermo Fisher Scientific, C6780) was added and a baseline was measured after a 5 min incubation
Temple fillers should only be injected by an experienced physician
Common experiences include no noticeable side effects at standard doses (250-500mcg for injectable, 500mcg for oral)
A consultation with a provider is recommended before starting treatment
Currently, there is only one drug in this class of medicationstirzepatide, which is approved as Mounjaro for treatment of Type 2 diabetes and as Zepbound for the treatment of obesity